Cargando…

Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials

Detalles Bibliográficos
Autores principales: Almas, Talal, Ehtesham, Maryam, Basit, Janita, Khedro, Tarek, Malik, Uzair, Nagarajan, Vikneswaran Raj, Hur, Jung, Alshareef, Norah, Fathima, Areen, Virk, Hafeez Ul Hassan, Hameed, Aamir, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844802/
https://www.ncbi.nlm.nih.gov/pubmed/35198169
http://dx.doi.org/10.1016/j.amsu.2022.103330
_version_ 1784651547784773632
author Almas, Talal
Ehtesham, Maryam
Basit, Janita
Khedro, Tarek
Malik, Uzair
Nagarajan, Vikneswaran Raj
Hur, Jung
Alshareef, Norah
Fathima, Areen
Virk, Hafeez Ul Hassan
Hameed, Aamir
Li, Jun
author_facet Almas, Talal
Ehtesham, Maryam
Basit, Janita
Khedro, Tarek
Malik, Uzair
Nagarajan, Vikneswaran Raj
Hur, Jung
Alshareef, Norah
Fathima, Areen
Virk, Hafeez Ul Hassan
Hameed, Aamir
Li, Jun
author_sort Almas, Talal
collection PubMed
description
format Online
Article
Text
id pubmed-8844802
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88448022022-02-22 Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials Almas, Talal Ehtesham, Maryam Basit, Janita Khedro, Tarek Malik, Uzair Nagarajan, Vikneswaran Raj Hur, Jung Alshareef, Norah Fathima, Areen Virk, Hafeez Ul Hassan Hameed, Aamir Li, Jun Ann Med Surg (Lond) Short Communication Elsevier 2022-02-07 /pmc/articles/PMC8844802/ /pubmed/35198169 http://dx.doi.org/10.1016/j.amsu.2022.103330 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Short Communication
Almas, Talal
Ehtesham, Maryam
Basit, Janita
Khedro, Tarek
Malik, Uzair
Nagarajan, Vikneswaran Raj
Hur, Jung
Alshareef, Norah
Fathima, Areen
Virk, Hafeez Ul Hassan
Hameed, Aamir
Li, Jun
Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
title Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
title_full Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
title_fullStr Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
title_full_unstemmed Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
title_short Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
title_sort prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: a critical appraisal of randomized controlled trials
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844802/
https://www.ncbi.nlm.nih.gov/pubmed/35198169
http://dx.doi.org/10.1016/j.amsu.2022.103330
work_keys_str_mv AT almastalal prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT ehteshammaryam prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT basitjanita prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT khedrotarek prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT malikuzair prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT nagarajanvikneswaranraj prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT hurjung prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT alshareefnorah prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT fathimaareen prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT virkhafeezulhassan prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT hameedaamir prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials
AT lijun prasugrelversusticagrelorforacutecoronarysyndromepatientsundergoingpercutaneouscoronaryinterventionacriticalappraisalofrandomizedcontrolledtrials